ALEMBIC PHARMACEUTICALS
|
ALEMBIC PHARMACEUTICALS Last 5 Year Income Statement History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| INCOME : | |||||
| Gross Sales | ₹6,229 Cr | ₹5,653 Cr | ₹5,306 Cr | ₹5,393 Cr | ₹4,606 Cr |
| Sales | ₹6,112 Cr | ₹5,500 Cr | ₹5,232 Cr | ₹5,276 Cr | ₹4,492 Cr |
| Job Work/ Contract Receipts | - | - | - | - | - |
| Processing Charges / Service Income | ₹12 Cr | ₹25 Cr | ₹15 Cr | ₹18 Cr | ₹21 Cr |
| Revenue from property development | - | - | - | - | - |
| Other Operational Income | ₹104 Cr | ₹128 Cr | ₹59 Cr | ₹99 Cr | ₹93 Cr |
| Less: Excise Duty | - | - | - | - | - |
| Net Sales | ₹6,229 Cr | ₹5,653 Cr | ₹5,306 Cr | ₹5,393 Cr | ₹4,606 Cr |
| EXPENDITURE : | |||||
| Increase/Decrease in Stock | ₹-143 Cr | ₹79 Cr | ₹-43 Cr | ₹-194 Cr | ₹-211 Cr |
| Raw Material Consumed | ₹1,858 Cr | ₹1,630 Cr | ₹1,490 Cr | ₹1,451 Cr | ₹1,250 Cr |
| Opening Raw Materials | ₹390 Cr | ₹456 Cr | ₹443 Cr | ₹294 Cr | ₹300 Cr |
| Purchases Raw Materials | ₹1,399 Cr | ₹1,184 Cr | ₹1,203 Cr | ₹1,276 Cr | ₹973 Cr |
| Closing Raw Materials | ₹386 Cr | ₹390 Cr | ₹517 Cr | ₹384 Cr | ₹294 Cr |
| Other Direct Purchases / Brought in cost | ₹455 Cr | ₹380 Cr | ₹361 Cr | ₹266 Cr | ₹271 Cr |
| Other raw material cost | - | - | - | - | - |
| Power & Fuel Cost | ₹173 Cr | ₹152 Cr | ₹121 Cr | ₹119 Cr | ₹102 Cr |
| Electricity & Power | ₹173 Cr | ₹152 Cr | ₹121 Cr | ₹119 Cr | ₹102 Cr |
| Oil, Fuel & Natural gas | - | - | - | - | - |
| Coals etc | - | - | - | - | - |
| Other power & fuel | - | - | - | - | - |
| Employee Cost | ₹1,446 Cr | ₹1,169 Cr | ₹1,133 Cr | ₹1,051 Cr | ₹906 Cr |
| Salaries, Wages & Bonus | ₹1,330 Cr | ₹1,072 Cr | ₹1,045 Cr | ₹966 Cr | ₹832 Cr |
| Contributions to EPF & Pension Funds | ₹81 Cr | ₹68 Cr | ₹60 Cr | ₹54 Cr | ₹51 Cr |
| Workmen and Staff Welfare Expenses | ₹35 Cr | ₹29 Cr | ₹28 Cr | ₹31 Cr | ₹24 Cr |
| Other Employees Cost | - | - | - | - | - |
| Other Manufacturing Expenses | ₹388 Cr | ₹409 Cr | ₹379 Cr | ₹372 Cr | ₹368 Cr |
| Sub-contracted / Out sourced services | - | - | - | - | - |
| Processing Charges | ₹68 Cr | ₹51 Cr | ₹19 Cr | ₹22 Cr | ₹18 Cr |
| Repairs and Maintenance | ₹81 Cr | ₹66 Cr | ₹52 Cr | ₹83 Cr | ₹51 Cr |
| Packing Material Consumed | - | - | - | - | - |
| Other Mfg Exp | ₹238 Cr | ₹293 Cr | ₹308 Cr | ₹267 Cr | ₹300 Cr |
| General and Administration Expenses | ₹526 Cr | ₹493 Cr | ₹414 Cr | ₹391 Cr | ₹340 Cr |
| Rent , Rates & Taxes | ₹18 Cr | ₹17 Cr | ₹15 Cr | ₹14 Cr | ₹15 Cr |
| Insurance | ₹21 Cr | ₹19 Cr | ₹18 Cr | ₹13 Cr | ₹7.50 Cr |
| Printing and stationery | - | - | - | - | - |
| Professional and legal fees | ₹199 Cr | ₹210 Cr | ₹191 Cr | ₹198 Cr | ₹147 Cr |
| Traveling and conveyance | ₹202 Cr | ₹171 Cr | ₹126 Cr | ₹108 Cr | ₹132 Cr |
| Other Administration | ₹86 Cr | ₹75 Cr | ₹64 Cr | ₹59 Cr | ₹38 Cr |
| Selling and Distribution Expenses | ₹997 Cr | ₹952 Cr | ₹890 Cr | ₹687 Cr | ₹531 Cr |
| Advertisement & Sales Promotion | ₹733 Cr | ₹681 Cr | ₹634 Cr | ₹502 Cr | ₹398 Cr |
| Sales Commissions & Incentives | - | - | - | - | - |
| Freight and Forwarding | ₹264 Cr | ₹271 Cr | ₹256 Cr | ₹186 Cr | ₹133 Cr |
| Handling and Clearing Charges | - | - | - | - | - |
| Other Selling Expenses | - | - | - | - | - |
| Miscellaneous Expenses | ₹51 Cr | ₹61 Cr | ₹48 Cr | ₹35 Cr | ₹104 Cr |
| Bad debts /advances written off | ₹2.86 Cr | ₹6.35 Cr | ₹5.24 Cr | ₹0.19 Cr | ₹0.48 Cr |
| Provision for doubtful debts | ₹5.36 Cr | - | ₹7.30 Cr | ₹6.06 Cr | ₹8.55 Cr |
| Losson disposal of fixed assets(net) | - | ₹4.70 Cr | - | - | - |
| Losson foreign exchange fluctuations | - | ₹0.09 Cr | - | - | - |
| Losson sale of non-trade current investments | - | - | - | - | - |
| Other Miscellaneous Expenses | ₹43 Cr | ₹50 Cr | ₹35 Cr | ₹29 Cr | ₹95 Cr |
| Less: Expenses Capitalised | - | - | - | - | - |
| Total Expenditure | ₹5,296 Cr | ₹4,945 Cr | ₹4,432 Cr | ₹3,913 Cr | ₹3,392 Cr |
| Operating Profit (Excl OI) | ₹933 Cr | ₹708 Cr | ₹874 Cr | ₹1,480 Cr | ₹1,214 Cr |
| Other Income | ₹29 Cr | ₹3.04 Cr | ₹50 Cr | ₹87 Cr | ₹14 Cr |
| Interest Received | ₹2.09 Cr | ₹0.33 Cr | ₹1.73 Cr | ₹1.58 Cr | ₹1.73 Cr |
| Dividend Received | ₹0.01 Cr | - | - | - | ₹0.01 Cr |
| Profit on sale of Fixed Assets | ₹1.70 Cr | - | ₹0.54 Cr | ₹1.39 Cr | ₹1.16 Cr |
| Profits on sale of Investments | ₹1.63 Cr | ₹0.61 Cr | ₹2.87 Cr | ₹4.95 Cr | ₹0.92 Cr |
| Provision Written Back | - | - | - | - | - |
| Foreign Exchange Gains | ₹18 Cr | - | ₹44 Cr | ₹77 Cr | ₹8.46 Cr |
| Others | ₹5.92 Cr | ₹2.10 Cr | ₹1.04 Cr | ₹2.28 Cr | ₹1.60 Cr |
| Operating Profit | ₹962 Cr | ₹711 Cr | ₹925 Cr | ₹1,568 Cr | ₹1,228 Cr |
| Interest | ₹56 Cr | ₹50 Cr | ₹18 Cr | ₹16 Cr | ₹27 Cr |
| InterestonDebenture / Bonds | - | - | - | - | - |
| Interest on Term Loan | - | - | - | - | - |
| Intereston Fixed deposits | - | - | - | - | - |
| Bank Charges etc | - | - | - | - | - |
| Other Interest | ₹56 Cr | ₹50 Cr | ₹18 Cr | ₹16 Cr | ₹27 Cr |
| PBDT | ₹905 Cr | ₹661 Cr | ₹907 Cr | ₹1,552 Cr | ₹1,201 Cr |
| Depreciation | ₹273 Cr | ₹275 Cr | ₹287 Cr | ₹183 Cr | ₹157 Cr |
| Profit Before Taxation & Exceptional Items | ₹633 Cr | ₹386 Cr | ₹620 Cr | ₹1,368 Cr | ₹1,043 Cr |
| Exceptional Income / Expenses | - | - | - | - | ₹-44 Cr |
| Profit Before Tax | ₹632 Cr | ₹355 Cr | ₹625 Cr | ₹1,368 Cr | ₹1,000 Cr |
| Provision for Tax | ₹16 Cr | ₹13 Cr | ₹104 Cr | ₹253 Cr | ₹199 Cr |
| Current Income Tax | ₹66 Cr | ₹4.20 Cr | ₹129 Cr | ₹255 Cr | ₹205 Cr |
| Deferred Tax | ₹-46 Cr | ₹9.20 Cr | ₹-23 Cr | ₹-9.56 Cr | ₹-4.30 Cr |
| Other taxes | ₹-3.74 Cr | ₹-0.80 Cr | ₹-1.25 Cr | ₹7.41 Cr | ₹-1.09 Cr |
| Profit After Tax | ₹616 Cr | ₹342 Cr | ₹521 Cr | ₹1,115 Cr | ₹801 Cr |
| Extra items | - | - | - | - | - |
| Minority Interest | - | - | - | - | ₹28 Cr |
| Share of Associate | - | - | - | ₹32 Cr | ₹0.06 Cr |
| Other Consolidated Items | - | - | - | - | - |
| Consolidated Net Profit | ₹616 Cr | ₹342 Cr | ₹521 Cr | ₹1,147 Cr | ₹829 Cr |
| Adjustments to PAT | - | - | - | - | - |
| Profit Balance B/F | ₹3,568 Cr | ₹2,554 Cr | ₹2,385 Cr | ₹1,559 Cr | ₹1,287 Cr |
| Appropriations | ₹4,184 Cr | ₹2,896 Cr | ₹2,906 Cr | ₹2,706 Cr | ₹2,116 Cr |
| General Reserves | - | ₹-869 Cr | - | ₹250 Cr | ₹200 Cr |
| Proposed Equity Dividend | - | - | - | - | - |
| Corporate dividend tax | - | - | - | - | ₹12 Cr |
| Other Appropriation | ₹157 Cr | ₹197 Cr | ₹351 Cr | ₹71 Cr | ₹176 Cr |
| Equity Dividend % | ₹550.00 | ₹400.00 | ₹500.00 | ₹700.00 | ₹500.00 |
| Earnings Per Share | ₹31.33 | ₹17.40 | ₹26.50 | ₹58.33 | ₹43.97 |
| Adjusted EPS | ₹31.33 | ₹17.40 | ₹26.50 | ₹58.33 | ₹43.97 |
Compare Income Statement of peers of ALEMBIC PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALEMBIC PHARMACEUTICALS | ₹17,692.0 Cr | -0.9% | -1.7% | -18% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹433,068.0 Cr | -0.2% | 7.1% | 1.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹171,847.0 Cr | 0.8% | -6% | 4.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹127,985.0 Cr | 1.2% | 6.4% | 13.1% | Stock Analytics | |
| CIPLA | ₹122,826.0 Cr | -0.2% | 1.4% | -0.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,418.0 Cr | 1.2% | 5.8% | 4.2% | Stock Analytics | |
ALEMBIC PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALEMBIC PHARMACEUTICALS | -0.9% |
-1.7% |
-18% |
| SENSEX | 0% |
2.7% |
6.8% |
You may also like the below Video Courses